MERTK is amplified in a small percentage of esophageal carcinomas and is overexpressed in the absence of gene amplification in many cancers, including multiple myeloma, gastric, prostate, breast, melanoma, and rhabdomyosarcoma (5, 14). This evidence concerns the gene MERTK and melanoma.